Skip to main content
OpenTrials

Clinical trial condition

Anemia, Sickle Cell

Explore clinical trials studying Anemia, Sickle Cell. Study availability and eligibility vary by location and protocol.

843 public trials 152 recruiting studies
Refine in advanced search Browse all conditions

Anemia, Sickle Cell trial results

Completed

Multi-Center Study of Iron Overload: Pilot Study

NCT01114776

Conditions
Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +16 more
Locations
  • Children's Hospital & Research Center Oakland Oakland, California, United States
  • Universitätsklinikum Hamburg-Eppendorf Hamburg-Eppendorf, Germany
  • UCL Cancer Institute London, United Kingdom
View Trial Details
Completed

Multi-Center Study of Iron Overload: Survey Study (MCSIO)

NCT01913548

Conditions
Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +16 more
Locations
  • Children's Hospital & Research Center Oakland Oakland, California, United States
  • Georgia Regents University Augusta, Georgia, United States
  • Children's Memorial Hospital Chicago, Illinois, United States
  • Adult Comprehensive Sickle Cell Center, Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG) Follow-up Observational Study II Protocol

NCT01783990

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's National Medical Center Center for Cancer and Blood Disorders Washington D.C., District of Columbia, United States
  • Howard University College of Medicine Washington D.C., District of Columbia, United States
  • University of Miami School of Medicine Miami, Florida, United States
View all 14 locations
View Trial Details
Completed

Long-Term Effects of Hydroxyurea in Children With Sickle Cell Anemia (The BABY HUG Follow-up Study)

NCT00890396

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +6 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Howard University College of Medicine Washington D.C., District of Columbia, United States
  • University of Miami School of Medicine Miami, Florida, United States
View all 14 locations
View Trial Details
Completed

Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia

NCT00006400

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +6 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Howard University Washington D.C., District of Columbia, United States
  • University of Miami Miami, Florida, United States
View all 14 locations
View Trial Details
Completed

A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia

NCT01179217

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +9 more
Locations
  • University of South Alabama Medical Center Mobile, Alabama, United States
  • Phoenix Children's Hospital Center for Cancer and Blood Disorders Phoenix, Arizona, United States
  • Kaiser Permanente Inglewood, California, United States
  • Children's Hospital & Research Center at Oakland Oakland, California, United States
View all 31 locations
View Trial Details

Related conditions